Results from Phase I study of PX-12, a thioredoxin inhibitor in patients with advanced solid malignancies
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: L. Kirkpatrick, T. Dragovich, R. Ramanathan, E. Sharlow, S. Chow, D. Williams, R. Himler, A. Baker, M. Egorin
Institution: UPMC Hillman Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4233874866
